Trial Profile

A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 03 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs IP 2018 (Primary)
Indications Depression; Erectile dysfunction
Focus Proof of concept; Therapeutic Use
Sponsors Initiator Pharma

Most Recent Events

28 Feb 2023 Planned End Date changed from 30 Jan 2023 to 30 Aug 2023.
28 Feb 2023 Planned primary completion date changed from 30 Nov 2022 to 30 Jul 2023.
01 Aug 2022 Planned End Date changed from 30 Nov 2021 to 30 Jan 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com